Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 16,085 | 8,549 | 12,054 | 6,427 | 11,320 |
| Cost of Goods | 6,034 | 3,148 | 3,703 | 4,733 | 4,765 |
| Gross Profit | 10,051 | 5,401 | 8,351 | 1,694 | 6,555 |
| Operating Expenses | 11,955 | 11,255 | 10,939 | 11,593 | 11,025 |
| Operating Income | -1,870 | -5,706 | -1,885 | -9,166 | -3,705 |
| Other Income | -416 | -961 | -2,314 | -2,075 | -1,770 |
| Pre-tax Income | -2,286 | -6,667 | -4,199 | -11,241 | -5,475 |
| Net Income Continuous | -2,286 | -6,667 | -4,199 | -11,241 | -5,475 |
| Net Income | $-2,286 | $-6,667 | $-4,199 | $-11,241 | $-5,475 |
| EPS Basic Total Ops | -0.05 | -0.14 | -0.09 | -0.25 | -0.14 |
| EPS Basic Continuous Ops | -0.05 | -0.15 | -0.09 | -0.25 | -0.14 |
| EPS Diluted Total Ops | -0.05 | -0.14 | -0.09 | -0.25 | -0.14 |
| EPS Diluted Continuous Ops | -0.05 | -0.15 | -0.09 | -0.25 | -0.14 |
| EBITDA(a) | $-1,525 | $-5,343 | $-959 | $-7,895 | $-2,474 |